Canada markets closed

Akari Therapeutics, Plc (CLA.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
1.4500+0.1500 (+11.54%)
At close: 09:24AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
7,825
9,561
9,133
8,820
Selling General and Administrative
13,412
13,527
8,081
9,161
Total Operating Expenses
21,238
23,088
17,214
17,981
Operating Income or Loss
-21,238
-23,088
-17,214
-17,981
Total Other Income/Expenses Net
11,251
5,294
-220.701
885.742
Income Before Tax
-9,890
-17,748
-17,424
-17,082
Income from Continuing Operations
-9,890
-17,748
-17,424
-17,082
Net Income
-9,890
-17,748
-17,424
-17,082
Net Income available to common shareholders
-9,890
-17,748
-17,424
-17,082
Basic EPS
-2.52
-5.69
-8.12
-20.00
Diluted EPS
-2.52
-5.69
-8.12
-20.00
Basic Average Shares
3,907
3,122
2,146
1,580
Diluted Average Shares
3,907
3,122
2,146
1,580